## Answer
(model generated chain of thought explanation)

### Initial Assessment:
The neonate is presenting with signs of meningitis, including fever, lethargy, and minimal responsiveness to stimuli. The lumbar puncture reveals a cloudy cerebrospinal fluid (CSF) with elevated protein levels, decreased glucose, increased pressure, and a high cell count (>90% polymorphonuclear neutrophils or PMN). The presence of gram-negative rods in the CSF is particularly concerning for bacterial meningitis.

### Next Steps:
Given the clinical presentation and microbiological findings, the next appropriate step in management should be to initiate antibiotic therapy. However, before starting antibiotics, it's essential to consider the following factors:

1. **Bacterial Identification**: While the presence of gram-negative rods suggests a possible bacterial cause, the exact type of bacteria (e.g., Neisseria meningitidis, Streptococcus pneumoniae) cannot be determined from the CSF alone.
2. **Risk of Over-Treatment**: Starting antibiotics without identifying the causative organism may lead to unnecessary treatment and potential harm due to antibiotic resistance or side effects.

### Management Options:
Considering these factors:

A. **Provide supportive measures only**: This option is not appropriate as it does not address the underlying cause of meningitis.
B. **MRI scan of the head**: While an MRI might be useful for evaluating the extent of brain involvement, it is not the immediate next step in managing suspected bacterial meningitis.
C. **Start the patient on IV cefotaxime**: This option addresses the need to identify and treat the likely causative organism (gram-negative rods) but does not consider the potential benefits of early antibiotic therapy in reducing morbidity and mortality.
D. **Start the patient on oral rifampin**: Rifampin is a potent bactericidal agent that can be effective against certain bacterial meningitis pathogens, including Neisseria meningitidis and Streptococcus pneumoniae. However, it should be used judiciously due to potential side effects (e.g., hepatotoxicity) and the need for close monitoring.

### Conclusion:
Given the clinical presentation and microbiological findings, the most appropriate next step in management is to start the patient on IV cefotaxime, which addresses the likely causative organism while considering the potential benefits of early antibiotic therapy. This approach balances the risk of over-treatment with the need for effective treatment.

Therefore, the answer is C.